Search Results - "NAKAHATA, HISASHI"

Refine Results
  1. 1

    Acid Cholesteryl Ester Hydrolase Activity of Mononuclear Leukocyte in Type 2 (Non-Insulin-Dependent) Diabetic Patients by ONUMA, TOMIO, TSUTSUI, MASAHIRO, OCHIAI, SHIGERU, BOKU, AKITOSHI, YANADA, ATSUKO, HIRAI, YUICHI, NAKAHATA, HISASHI, TAKEBE, KAZUO

    “…ONUMA, T., TSUTSUI, M., OCHIAI, S., BOKU, A., YANADA, A., HIRAI, Y., NAKAHATA, H. and TAKEBE, K. Acid Cholesteryl Ester Hydrolase Activity of Mononuclear…”
    Get full text
    Journal Article
  2. 2

    Peripheral lymphocyte subset of patients with pancreatic diabetes mellitus--about a decreased ratio of T-LGL and ability of host defense by Tsujino, M, Kinpara, I, Nakamura, T, Suda, T, Saitou, Y, Kudou, H, Yasujima, M, Hirai, Y, Nakahata, H, Kumasaka, Y, Imamura, K, Takebe, K

    Published in Kansenshōgaku zasshi (01-04-1996)
    “…Patients with diabetes mellitus (DM) often suffer from various and severe infection. Patients with pancreatic DM have malnutrition due to chronic pancreatitis…”
    Get more information
    Journal Article
  3. 3

    Basic and clinical studies on temafloxacin by Hirai, Yuichi, Tsujino, Moriyasu, Nakahata, Hisashi, Aoki, Rumiko, Takebe, Kazuo

    Published in CHEMOTHERAPY (1993)
    “…Laboratory and clinical studies were performed on a new quinolone derivative, temafloxacin (TMFX). The bactericidal activity of human polymorphonuclear…”
    Get full text
    Journal Article
  4. 4

    Clinical studies on loracarbef by Takebe, Kazuo, Tsutsui, Masahiro, Nakahata, Hisashi, Ogawa, Yoshiji, Imamura, Kenichi

    Published in CHEMOTHERAPY (1993)
    “…We evaluated the clinical efficacy and safety of loracarbef, a new oral carbacephem antibiotic, administered at a dose 600 mg a day for 4-14 days in 7 patients…”
    Get full text
    Journal Article
  5. 5

    CLINICAL STUDIES OF SPARFLOXACIN by Takebe, Kazuo, Nakamura, Teruo, Sagara, Morio, Okamoto, Katsuhiro, Nakahata, Hisashi, Ogawa, Yoshiji, Miyazawa, Tadashi, Imamura, Kenichi

    Published in CHEMOTHERAPY (1991)
    “…Sparfloxacin (SPFX) is a new oral antimicrobial agent which is a pyridone carboxylic acid derivative developed by Dainippon Pharmaceutical Co., Ltd. SPFX was…”
    Get full text
    Journal Article
  6. 6

    S-1108 in respiratory tract infections by Takebe, Kazuo, Matsukawa, Masakatsu, Nakahata, Hisashi, Masuda, Mitsuo, Murakami, Seiichi, Imamura, Kenichi, Tamura, Toyokazu

    Published in CHEMOTHERAPY (30-06-1993)
    “…S-1108 was administered to 13 patients with respiratory tract infection. Clinical efficacy and safety were evaluated. 1) Thirteen patients with respiratory…”
    Get full text
    Journal Article
  7. 7

    Clinical study of tazobactam/piperacillin by Takebe, Kazuo, Tamura, Toyokazu, Imamura, Kenichi, Masuda, Mitsuo, Murakami, Seiichi, Murabayashi, Shuya, Suzuki, Kazue, Nakahata, Hisashi, Matsukawa, Masakatsu, Osonoi, Takeshi, Saito, Miyoko, Fukumoto, Yoshihiro, Kuroda, Yasuhisa, Nakayama, Shoichi

    Published in CHEMOTHERAPY (1994)
    “…A newly developed, β-lactamase-inhibitor-combined agent for injection, tazobactam/piperacillin, was clinically studied in respiratory tract infections at…”
    Get full text
    Journal Article
  8. 8

    CLINICAL STUDY ON CEFCLIDIN by Takebe, Kazuo, Masuda, Mitsuo, Murakami, Seiichi, Tomiyama, Tsukiko, Nakahata, Hisashi, Arai, Keiko, Sagara, Morio, Tamura, Toyokazu, Endo, Katsumi, Katano, Haruto

    Published in CHEMOTHERAPY (1992)
    “…We evaluated the clinical efficacy and safety of cefclidin (CFCL), a new cephalosporin, at a dose of 0.5-1.0g twice daily for 6-15 days in 15 patients with…”
    Get full text
    Journal Article
  9. 9

    In vivo antibacterial activity of cefbuperazone. Synergy of cefbuperazone for bactericidal effect with human polymorphonuclear leukocytes by Kumasaka, Y, Nakahata, H, Hirai, Y, Imamura, K, Takebe, K, Suzuki, I, Senda, H

    Published in Japanese journal of antibiotics (01-01-1986)
    “…Studies were done utilizing E. coli No. 59 which are resistant against human and mouse serum, and the following results were obtained. The therapeutic effect…”
    Get more information
    Journal Article
  10. 10

    DISULFIRAM-LIKE REACTIONS RESULTING FROM ADMINISTRATION OF CEPHEMS WITH METHYLTETRAZOLETHIOL: AN ANALYSIS OF LIVER ACETALDEHYDE DEHYDROGENASE ACTIVITY by NAKAHATA, HISASHI, HIRAI, YUICHI, KUMASAKA, YOSHIHIRO, MIYAZAWA, TADASHI, NAKAMURA, TERUO, IMAMURA, KENICHI, MAKINO, ISAO, TAKEBE, KAZUO

    Published in CHEMOTHERAPY (25-11-1985)
    “…The mechanism of disulfiram-like reactions due to cephems with methyltetrazolethiol (LMOX and CPZ) was studied. Rats were intraperitoneally injected with these…”
    Get full text
    Journal Article
  11. 11

    CLINICAL STUDY ON CEFPIROME by TAKEBE, KAZUO, MASUDA, MITSUO, MURAKAMI, SEIICHI, SAGARA, MORIO, OKAMOTO, KATSUHIRO, NAKAHATA, HISASHI, KAWAGISIH, TAKAHIKO, BOKU, AKITOSHI, GASA, KEIKO, MIYAZAWA, TADASHI, IMAMURA, KENICHI, TAMURA, TOYOKAZU, ENDO, KATSUMI, KIMURA, KENICHI

    Published in CHEMOTHERAPY (1991)
    “…Cefpirome was administered intravenously to 16 patients with respiratory tract infections at 1-2 g b.i.d. for 4-15 days. Clinical efficacy was excellent in 3…”
    Get full text
    Journal Article
  12. 12

    SYNERGETIC BACTERICIDAL EFFECT OF CEFIJZONAM WITH HUMAN POLYMORPI-IONUCLEAR LEUKOCYTES by Hirai, Yuichi, Nakahata, Hisashi, Aoki, Rumiko, Tsujino, Moriyasu, Kumasaka, Yoshihiro, Takebe, Kazuo

    Published in CHEMOTHERAPY (25-05-1991)
    “…We evaluated the synergetic bactericidal effect of cefuzonam (CZON), a new cephemantibiotic, and human polymorphonuclear leukocytes (PMNs), using Evlicrichia…”
    Get full text
    Journal Article
  13. 13

    EFFECT OF AC-1370 ON SUPEROXIDE ANION (O2-) PRODUCTION BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES by KUMASAKA, YOSHIHIRO, NAKAHATA, HISASHI, HIRAI, YUICHI, IMAMURA, KENICHI, TAKEBE, KAZUO

    Published in CHEMOTHERAPY (1984)
    “…Effect of AC-1370, a new semisynthetic cephalosporin antibiotic, on superoxide anion (O2-) production by human polymorphonuclear leukocytes (PMNs) was…”
    Get full text
    Journal Article
  14. 14

    FUNDAMENTAL STUDY ON CEFOTETAN (YM09330) by KUMASAKA, YOSHIHIRO, NAKAHATA, HISASHI, IMAMURA, KENICHI, TAKEBE, KAZUO

    Published in CHEMOTHERAPY (20-04-1982)
    “…Fundamental study on cefotetan (CTT, YM09330), a new semisynthetic cephamycin antibiotic, was carried out and following results were obtained. 1. Antibacterial…”
    Get full text
    Journal Article
  15. 15

    FUDAMENTAL STUDY ON AM-715 by KUMASAKA, YOSHIHIRO, NAKAHATA, HISASHI, IMAMURA, KENICHI, TAKEBE, KAZUO

    Published in CHEMOTHERAPY (25-12-1981)
    “…Fundamental study on AM-715, a new chemotherapeutic agent, was carried out and following results were obtained. 1) Antibacterial activities: The MICs of AM-715…”
    Get full text
    Journal Article
  16. 16

    Disulfiram-like reactions resulting from the administration of cephem antibiotics with methyltetrazolethiol moiety examined by using different doses by Nakahata, H, Hirai, Y, Kumasaka, Y, Miyazawa, T, Nakamura, T, Imamura, K, Makino, I, Takebe, K, Kudo, H

    Published in Japanese journal of antibiotics (01-03-1986)
    “…The disulfiram-like reactions following the treatment of cephem antibiotics with methyltetrazolethiol moiety (latamoxef (LMOX) and cefoperazone (CPZ) was…”
    Get more information
    Journal Article
  17. 17

    DISULFIRAM-LIKE REACTIONS RESULTING FROM ADMINISTRATION OF CEPHEMS WITH METHYLTETRAZOLETHIOL IN THE RATS WITH LIVER DYSFUNCTION by NAKAHATA, HISASHI, HIRAI, YUICHI, KUMASAKA, YOSHIHIRO, MIYAZAWA, TADASHI, NAKAMURA, TERUO, IMAMURA, KENICHI, MAKINO, ISAO, TAKEBE, KAZUO

    Published in CHEMOTHERAPY (1985)
    “…The influence of liver dysfunction on the disulfiram-like reactions due to cephems with methyltetrasolethiol was studied. The rats with fatty liver and…”
    Get full text
    Journal Article
  18. 18

    CLINICAL STUDY OF CEFTRIAXONE (Ro 13-9904) by TAKEBE, KAZUO, SASAKI, KAZUO, KUMASAKA, YOSHIHIRO, MAKINO, ISAO, NAKAMURA, TERUO, TAKAHASHI, KIYOHITO, NAKAHATA, HISASHI, OSONOI, TAKESHI, KURIHARA, AIICHIRO, WATANABE, HAJIME, TAMURA, TOYOKAZU, MASAKI, NAOYOSHI, SAGARA, MORIO, YASHIRO, HITOSHI

    Published in CHEMOTHERAPY (1984)
    “…Ceftriaxone (CTRX, Ro 13-9904) was studied about its clinical efficacy, side effects and laboratory values with 20 cases of infectious diseases: 10 cases with…”
    Get full text
    Journal Article
  19. 19

    CLINICAL STUDIES ON TA-058 by TAKEBE, KAZUO, KUDO, MIKIHIKO, KUMASAKA, YOSHIHIRO, NAKAHATA, HISASHI, MAKINO, ISAO, OHMI, TADANAO, TAKAHASHI, SHUICHI, YOSHIDA, SHUICHIRO, OKAMOTO, KATSUHIRO, MURAKAMI, SEIICHI, MORI, YUZO, KIMURA, KENICHI, MACHIDA, KOJI, KOSAKA, SHIRO

    Published in CHEMOTHERAPY (1984)
    “…To evaluate the clinical efficacy of TA-058, the treatment was made with the drug in 17 patients including 5 with bacterial pneumonia, 2 with primary atypical…”
    Get full text
    Journal Article
  20. 20

    CLINICAL STUDIES ON CEFTIZOXIME (CZX) by TAKEBE, KAZUO, KUMASAKA, YOSHIHIRO, IMAMURA, KENICHI, ONUMA, TOMIO, BABA, TSUNEHARU, SAGARA, MORIO, OHIRA, SEIICHI, MATSUHASHI, AKIO, MASUDA, MITSUO, KITAOKA, MASABUMI, YOSHIOKA, MITSUHARU, ENOOKA, GEN, NAKAHATA, HISASHI

    Published in CHEMOTHERAPY (01-01-1980)
    “…To evaluate the clinical efficacy of Ceftizoxime (CZX, FK 749), the treatment was made with the drug in 16 patients including 1 with pneumonia and 15 with…”
    Get full text
    Journal Article